1. Biostatistics Center, Massachusetts General Hospital Cancer Center, Boston, Massachusetts 02114, United States
2. Proteomics
Platform, Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, Massachusetts 02142, United States
3. Personalized
Diagnostics, The Biodesign Institute, Arizona State University, Tempe, Arizona 85287, United States
4. The Plasma Proteome Institute, Washington, D.C. 20009, United States
5. SISCAPA Technologies, Inc., Washington, D.C. 20009, United States
6. Jim Ayers Institute for Precancer Detection
and Diagnosis and Department of Biochemistry, Vanderbilt University, School of Medicine, Nashville, Tennessee 37232, United States
7. Division
of Gastroenterology and Hepatology, Department of Medicine, University of North Carolina, Chapel Hill, North Carolina 27514, United States
8. Department of Laboratory Medicine, Children’s Hospital Boston, Boston, Massachusetts 02115, United States
9. Department of Pathology, Harvard Medical School, Boston, Massachusetts 02115, United States
10. King Abdulaziz University, Jeddah 22254, Saudi Arabia
11. Office of In Vitro Diagnostics and Radiological Health, Center for
Devices and Radiological Health, Food and Drug Administration, Department of Health and Human Services, Silver Spring, Maryland 20993, United States
12. Division of Biomedical Statistics and Informatics, Department
of Health Sciences Research, Mayo Clinic, Rochester, Minnesota 55905, United States
13. Fujirebio Diagnostics, Inc., Malvern, Pennsylvania 19355, United States
14. Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health & Human Services, Bethesda, Maryland 20892, United States
15. Office of Cancer Clinical Proteomics Research, Center for Strategic Scientific Initiatives, National Cancer Institute, National Institutes of Health, Department of Health & Human Services, Bethesda, Maryland 20892, United States